Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1904  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3785    
    Printed182    
    Emailed6    
    PDF Downloaded216    
    Comments [Add]    
    Cited by others 12    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2010  |  Volume : 58  |  Issue : 4  |  Page : 560--564

Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion


1 Department of Pediatrics, Government Multi Speciality Hospital, Sector 16, Chandigarh- 160 015, India
2 Department of Radiology, Government Multi Speciality Hospital, Sector 16, Chandigarh- 160 015, India

Correspondence Address:
Neeraj Dhawan
H. No. 6144, MHC, Manimajra, Chandigarh- 160 101
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.68677

Rights and Permissions

Background : The appropriate duration of albendazole therapy in neurocysticercosis is uncertain. The observation in small uncontrolled randomized trials in children that short-course therapy (1 week) is as effective as the conventional regimen (4weeks) must be tested. Objective : To compare the efficacy of 1 and 4 weeks of albendazole therapy in children with single small enhancing computed tomographic lesion (SSECTL). Study Design: An open-labeled, randomized, clinical trial. Materials and Methods : One hundred twenty children with SSECTLs presenting with seizure. Intervention: The subjects were assigned to two groups using random tables: group A (n=58) received albendazole for 1 week and group B (n=62) for 4 weeks. All the subjects were followed up for 6 months. Results : The proportions of subjects with complete resolution of lesion in the two groups were similar (group A 63.8% versus group B 51.6%). The proportion of subjects in the two groups in whom the lesion calcified on follow up (group A 19% versus group B 24.2%) also did not differ significantly. The incidence of seizure recurrence during the 6-month follow-up period was also similar in both the groups (group A 9.6% versus group B 3.4%, P > 0.05). Conclusion : One week of albendazole therapy is as effective as 4 weeks of therapy in children with SSECTLs.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow